CPHI to Hold Fiscal Year 2012 Earnings Conference Call on Friday, March 15,
2013 at 8:30 a.m. ET
HAIKOU CITY, China, March 5, 2013
HAIKOU CITY, China, March 5, 2013 /PRNewswire/ -- China Pharma Holdings, Inc.
("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets
specialty pharmaceutical products in China, today announced that it plans to
hold its fiscal year 2012 earnings conference call on Friday, March 15, 2013
at 8:30 a.m. ET.
Listeners may access the call by dialing 1-866-519-4004 or 65-672-393-81 for
international callers, Conference ID # 15878326. A webcast will also be
available through CPHI's website at http://www.chinapharmaholdings.com.A
replay of the call will be accessible through March 22, 2013 by dialing
1-855-452-5696 or 61-281-990-299 for international callers, Conference ID #
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly
growing profit that develops, manufactures, and markets treatments for a wide
range of high incidence and high mortality conditions in China, including
cardiovascular, CNS, infectious, and digestive diseases. The Company's
cost-effective, high margin business model is driven by market demand and
supported by eight scalable GMP-certified product lines covering the major
dosage forms. In addition, the Company has a broad and expanding distribution
network across 30 provinces, municipalities and autonomous regions. The
Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology
Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a
wholly owned subsidiary of China Pharma Holdings, Inc. For more information
about China Pharma Holdings, Inc., please visit
China Pharma Holdings, Inc.
Phone: +86-898-6681-1730 (China)
SOURCE China Pharma Holdings, Inc.
Press spacebar to pause and continue. Press esc to stop.